ArticleRespirology case reports2025

Secondary Organising Pneumonia Among Immunocompromised Multiple Sclerosis Patients Treated With Ocrelizumab Following COVID-19 Infection: Two Case Reports With Literature Review.

Tarake M Aljarod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.